Brown Brothers Harriman & Co’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Brown Brothers Harriman & Co’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,000	Closed	-$15	–	1241
2021 Q2	$15	Buy	+2,000	New	+$15.4K	﹤0.01%	853
2020 Q1	–	Sell	-1,838	Closed	-$3K	–	1342
2019 Q4	$3K	Hold	1,838	–	–	﹤0.01%	1022
2019 Q3	$3K	Hold	1,838	–	–	﹤0.01%	1056
2019 Q2	$5K	Hold	1,838	–	–	﹤0.01%	902
2019 Q1	$9K	Hold	1,838	–	–	﹤0.01%	855
2018 Q4	$8K	Buy	+1,838	New	+$14.2K	﹤0.01%	721

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Brothers Harriman & Co's SURF Position: Q3 2021 in Review

Brown Brothers Harriman & Co sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2021, closing a stake of 2,000 shares — an estimated $15 sold.

Brown Brothers Harriman & Co first reported a position in SURF in Q4 2018 and held it in 6 quarters. The position peaked at $9K in Q1 2019. 91 funds tracked by Wall St. Rank hold SURF as of Q3 2021.

Brown Brothers Harriman & Co reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Brown Brothers Harriman & Co sold 2,000 Surface Oncology, Inc. Common Stock shares in Q3 2021, an estimated $15.
Brown Brothers Harriman & Co first reported a position in Surface Oncology, Inc. Common Stock in Q4 2018 and held it in 6 quarters.
Brown Brothers Harriman & Co's Surface Oncology, Inc. Common Stock position peaked at $9K in Q1 2019.
91 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2021.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2021, filed 15 Nov 2021.